Home > Products > CD33 & CD64
> Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv) (CAT#: IGFV-115)
Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv) is designed to be expressed as a LC and an extended HC with scFv moiety linked to the C terminus. It is a symmetric bispecific and tetravalent molecule, bivalent for each antigen specificity, 2+2 antigen-binding valency. This BsAb can retarget neutrophils cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
FCGR1A; Fc fragment of IgG receptor Ia; CD64; FCRI; CD64A; IGFR1; Cluster of Differentiation 64; FcγRI; FCGR1B; FCGR1C; immunoglobulin G Fc receptor high affinity I; Fc gamma RI
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
There are currently no customer reviews or questions for Recombinant Anti-CD33 x Anti-CD64 Bispecific Antibody (IgG-scFv) (IGFV-115). Click the button below to contact us or submit your feedback about this product.